期刊文献+

2010年河南省麻疹减毒活疫苗强化免疫疑似预防接种异常反应监测分析 被引量:1

Analysis on the Adverse Event Following Immunization after Supplementary Immunization Activity of Measles Attenuated Live Vaccine in Henan Province in 2010
原文传递
导出
摘要 目的分析2010年河南省开展麻疹减毒活疫苗(Measles Attenuated Live Vaccine,MV)强化免疫活动(SupplementaryImmunization Activity,SIA)后,疑似预防接种异常反应(Adverse Events Following Immunization,AEFI)的发生特征,探讨MV SIA的安全性。方法采用描述性方法对相关指标进行流行病学分析。结果 2010年河南省MV SIA活动共报告AEFI 872例,发生率4.31/10万剂;男性多于女性。>80%的AEFI出现在接种后<2 d;临床损害以红肿、发热和过敏性皮疹等为主;绝大多数病例预后良好。结论 MV SIA的AEFI监测敏感性高,疫苗安全性良好,接种对象在接种MV后<2 d是监测的重点。 Objective To analyze the characteristics and regular patterns of adverse events following immunization ( AEFI )after supplementary immunization activity (SIA)of Measles attenuated live vaccine (MV)in Henan province in 2010, and to discuss the safety of MV SIA. Methods The descriptive epidemiology analysis on related indexes were conducted. Results 874 cases of AEFI were reported in MV SIA in 2010. The incidence rate was 4.31 per 100, 000 doses, and male was higher than female; more than 80% AEFI occurred within 2 days after vaccination. Allergic reaction is the main reaction of vaccination. Most of the cases were cured. Conclusions Surveillance of AEFI following MV SIA within 2 day after vaccination is the priority population. The sensitivity of the surveillance system is high, MMV is safe.
出处 《河南预防医学杂志》 2012年第6期444-447,共4页 Henan Journal of Preventive Medicine
关键词 麻疹减毒活疫苗 强化免疫活动 疑似预防接种异常反应 发生率 监测 Measles and Mumps combined attenuated live vaccine Supplementary immunization activity Adverse events followinimmunization Incidence Surveillance
  • 相关文献

参考文献6

二级参考文献20

  • 1张守荣,赵建海,朱向路,张永基,马小军.青海省2006年麻疹疫苗强化免疫结果分析[J].青海医药杂志,2008,38(6):9-11. 被引量:7
  • 2朱青,童亦兵,张大勇,杜雯.贵州省麻疹疫苗强化免疫试点结果分析[J].中国计划免疫,2004,10(5):288-291. 被引量:24
  • 3卫生部.预防接种异常反应鉴定办法[S].2008.
  • 4中国疾病预防控制中心.麻疹疫苗强化免疫活动指南[S].2006.
  • 5WHO.Supplementary information on vaccine safety.Part 2:Background rates of adverse events following immunization[M].Geneva:WH0/V& B/00,2000:61-64.
  • 6卫生部.全国疑似预防接种异常反应监测方案[S].2010-06-03.
  • 7世界卫生组织西太平洋区办事处.消除麻疹现场指南.中国计划免疫,2005,.
  • 8Salisbury DM, Campbell H, Edwards B. Measles Rubella Immunization Campaign in England[M]. "One Year On". London: Health Promotional Division & Medicines Control Agency, Department of Health, 1995:281-282.
  • 9Weigong Zhou, Vitali Pool, John K, et al. Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS), United States, 1991-2001 [J]. MMWR, 2003, 52 (SS01) :1-24.
  • 10WHO. Supplementary information on vaccine safety. Part 2: Background rates of adverse events following immunization[M]. Geneva: WH0/V & B/00, 2000: 61-64.

共引文献67

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部